ArticleCureus2026
Dual Diagnosis of Thyroid Amyloidosis and Lipomatosis: An Uncommon Concurrence.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lipoid lesions of the thyroid are extremely rare. Adipose changes can be seen in both malignant (carcinomas) and benign conditions. The two most common benign entities are thyrolipoma and thyrolipomatosis, which have been reportedly associated with systemic amyloidosis. Radiologically, these lesions can mimic malignancy, especially when presenting as a biochemically active condition. We present a rare case of concurrent thyroid lipomatosis and serum amyloid A amyloidosis (AA) manifesting as goiter and subclinical hyperthyroidism. A 72-year-old male presented to Danbury Hospital with complaints of hoarseness of voice and reduced neck movement. His past medical history was significant for Crohn's disease, ankylosing spondylitis, monoclonal gammopathy of undetermined significance (MGUS), and AA amyloidosis involving bilateral kidneys with end-stage kidney disease (ESKD) status post renal transplantation. AA amyloidosis secondary to Crohn's disease led to bilateral kidney involvement and ESKD, requiring renal transplantation. Fine-needle aspiration of the left lower lobe in 2021 confirmed thyroid gland involvement, revealing atypical follicular cells with colloid present, classified as Bethesda Category III, with Congo red staining demonstrating amyloid deposition. Physical examination revealed severely enlarged thyroid glands causing compressive symptoms. Thyroid function tests indicated subclinical hyperthyroidism. Thyroid ultrasound revealed a right lobe measuring 9.0 × 5.5 × 4.8 cm and a left lobe measuring 9.0 × 5.5 × 4.3 cm, with a bilateral increase in size compared to imaging from two years prior. The left thyroid gland had a lower pole hypoechoic nodule measuring 1.0 × 1.0 × 0.8 cm, with mixed cystic and solid composition and smooth margins. No pathologically enlarged or morphologically abnormal cervical lymph nodes were identified on imaging. On follow-up, a total thyroidectomy with intraoperative nerve monitoring was performed. During follow-up in 2024, sonographically guided fine-needle aspiration of the left lower pole thyroid nodule was classified as unsatisfactory (Bethesda Category I), showing sheets of degenerated and anucleated squamous cells with debris, but no follicular cells. Thyroidectomy was subsequently performed due to symptomatic goiter with compressive symptoms. Gross examination of the specimen showed an abnormally enlarged thyroid gland with a diffusely yellowish cut surface. Hematoxylin and eosin (H&E) staining showed eosinophilic, amorphous, extracellular deposits, with diffuse infiltration of mature adipocytes in the thyroid stroma. A few entrapped residual thyroid follicles were observed. Congo red stain confirmed amyloid deposition, exhibiting apple-green birefringence under polarized light. Thyroid amyloid deposits are rare. Associated with chronic inflammatory conditions, including rheumatoid arthritis, ankylosing spondylitis, Crohn's disease, and familial Mediterranean fever (FMF). This case study illustrates the rare concurrence of thyroid lipomatosis and AA amyloidosis. It is thought that chronic hypoxia from AA amyloid-induced capillary damage: the driver of fibroblast-to-adipocyte metaplasia. Progression of this process resulted in diffuse replacement of the thyroid parenchyma with adipocytes and goitrous enlargement requiring resection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.